Countries SEA Countries

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced b...

 June 07, 2023 | News

YS Biopharma's PIKA Rabies Vaccine Approved for Phase 3 Clinical Trials by Philippines FDA

The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...

 June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

 June 01, 2023 | News

Malaysian Genomics Inks Agreement in Expansion to Bangladesh

 Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic coope...

 May 16, 2023 | News

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

  –Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

 May 01, 2023 | News

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

 April 26, 2023 | News

CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023

“Historically, we have seen a dual strategy of focusing on China and the US for emerging innovators in China. However, a series of recent setbacks wi...

 April 13, 2023 | News

FINN Partners & Galen Growth will Host Digital Health Investment Summit in Boston

Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas    Galen Growth, the...

 April 12, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

 April 12, 2023 | News

Pharma marketing future and present: AI & Modular Content in APAC focus

At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...

 March 31, 2023 | News

Earable Neuroscience and Excelpoint Partner to Commercialize AI-Powered FRENZ Brainband for Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...

 March 31, 2023 | News

The Rapidly Growing Biopharma Industry in Southeast Asia: Which Countries are Leading the Way?

Singapore: A Biopharma Hub Singapore is one of the most prominent players in the Southeast Asian biopharma industry. It has positioned itself as a hub for...

 March 31, 2023 | News

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

  Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical tr...

 March 31, 2023 | News

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

 March 29, 2023 | Influencers


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close